BRIGHT-4: Is Bivalirudin Poised for a Comeback in STEMI PCI? BRIGHT-4: Is Bivalirudin Poised for a Comeback in STEMI PCI?

Results of the massive Chinese trial strongly favor bivalirudin over heparin but years of practice and cost concerns may be too much to overcome, observers say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news